Overview


According to FutureWise analysis the market for animal intestinal health in 2023 is US$ 4.01 billion, and is expected to reach US$ 7.66 billion by 2031 at a CAGR of 8.4%.

Animal intestinal health refers to the overall well-being and proper functioning of the digestive system in animals, including mammals, birds, and reptiles. It encompasses a range of factors, such as the balance of gut microbiota, the integrity of the intestinal lining, efficient nutrient absorption, and the prevention of digestive disorders. A healthy intestinal system is crucial for animals to obtain essential nutrients from their diet, maintain a strong immune system, and overall sustain optimal health. Various factors, including diet, stress, infections, and environmental conditions, can influence animal intestinal health.

Intestinal health is an integral part of economic animal production as more than 80% of the transverse through the gastrointestinal tract. Also termed gut health, it covers the macro and microenvironment of the gut, microbiota balance, the integrity of the gut tissues, and the status of the gastrointestinal tract's immune system. The gut consumes about one-fifth of the consumed energy and hosts most microorganisms, multiple hormones, digestive juices, etc. For food-producing animals, maintaining gut health is of utmost importance to ensure the production of safe animal protein for human consumption, achieved by improving disease resistance and optimizing the animal's fulfillment of its genetic potential.

FutureWise Market Research has published a report that provides an insightful analysis animal intestinal health market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, animal intestinal health market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Koninklijke DSM N.V. 
  • Archer Daniels Midland Company 
  • Kemin Industries, Inc.
  • DuPont 
  • Cargill, Incorporated 
  • Novozymes 
  • Nutreco N.V. 
  • Chr. Hansen Holding A/S 
  • Bluestar Adisseo Co Ltd. 
  • Alltech 
  • Evonik Industries 
  • Lallemand, Inc. 
  • Biorigin 
  • AB Vista 
  • Land O'Lakes 
  • Lesaffre 
  • Calpis Co., Ltd 
  • Unique Biotech
  • Pure Cultures
  • Dr. Eckel Animal Nutrition GmbHCo. KG 

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Additive

  • Probiotics
  • Prebiotics
  • Phytogenics
  • Immunostimulants

By Form

  • Dry
  • Liquid

By Livestock

  • Poultry
    • Broilers
    • Layers
    • Turkey
    • Other poultry species (game birds and duck)
  • Ruminant
    • Dairy cattle
    • Beef cattle
    • Calves
    • Other ruminant species (goats and sheep)
  • Swine
  • Aquaculture
  • Other livestock (equine and pet)

By Source

  • Microbial
  • Plant-based

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Animal Intestinal Health Market By Additive, By Form, By Livestock, By Source and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-Product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
     

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Animal Intestinal Health Market Variables, Trends and Scope
    •          1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Animal Intestinal Health Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Global Animal Intestinal Health Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Global Animal Intestinal Health Market, By Additive Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Probiotics
        2. Prebiotics
        3. Phytogenics
        4. Immunostimulants

  • 8.   Global Animal Intestinal Health Market, By Form Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Dry
        2. Liquid

  • 9.   Global Animal Intestinal Health Market, By Livestock Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Poultry
         1.1. Broilers
         1.2. Layers
         1.3. Turkey
         1.4. Other poultry species (game birds and duck)
        2. Ruminant
         2.1. Dairy cattle
         2.2. Beef cattle
         2.3. Calves
         2.4. Other ruminant species (goats and sheep)
        3. Swine
        4. Aquaculture
        5. Other livestock (equine and pet)

  • 10.   Global Animal Intestinal Health Market, By Source Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Microbial
        2. Plant-based

  • 11.   North America Animal Intestinal Health Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Animal Intestinal Health Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Animal Intestinal Health Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Animal Intestinal Health Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Koninklijke DSM N.V. (Netherlands)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Archer Daniels Midland Company (US)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Kemin Industries, Inc.(US)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DuPont (US)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cargill, Incorporated (US)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Novozymes (Denmark)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nutreco N.V. (Netherlands)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Chr. Hansen Holding A/S (Denmark)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Bluestar Adisseo Co Ltd. (China)
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Alltech (US)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Evonik Industries (Germany)
         11.1.Company Overview
         11.2.Product Portfolio
         11.3.SWOT Analysis
         11.4.Financial Overview
         11.5.Strategic Overview
        12. Lallemand, Inc. (Canada)
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Biorigin (Brazil)
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. AB Vista (UK)
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Land O'Lakes (US)
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Lesaffre (France)
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Calpis Co., Ltd (Japan)
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Unique Biotech (India)
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Pure Cultures
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Dr. Eckel Animal Nutrition GmbHCo. KG (Germany)
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients